Prevalence of Weight Loss Product Use 5.5 Percent in Teens
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
WEDNESDAY, Jan. 10, 2024 -- Overall, 5.5 percent of adolescents use weight-loss products, with higher use among girls, according to a systematic review and meta-analysis published online Jan. 10 in JAMA Network Open.
Natasha Yvonne Hall, Pharm.B., from the School of Health and Social Development at Deakin University in Melbourne, Australia, and colleagues examined the global prevalence of nonprescription weight-loss product use in children and adolescents in a meta-analysis of 90 articles with 604,552 unique participants (56 percent of studies from North America).
The researchers found that the reported prevalence of nonprescription weight-loss product use was 5.5 percent in adolescents overall. Prevalence was 2.0, 4.4, 6.2, and 8.9 percent in the past week, past month, past year, and lifetime, respectively, when identifying use of weight-loss products in the general population. Girls had higher use of weight-loss products than boys.
"Prevalence of weight-loss product use was higher in North America compared with Asia and Europe and was higher in Asia compared with Europe," the authors write. "Given the individual and public health issues associated with adolescent use of nonprescription weight-loss products, interventions are urgently required to prevent and regulate use of weight-loss products in this population."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-01-11 08:15
Read more

- FDA Suspends U.S. License of Chikungunya Vaccine
- 26.5 Percent of Adults With Diabetes Used GLP-1 RA Injectables in 2024
- Lack of Proper Child Passenger Restraints Seen in Majority of Fatal Car Crashes
- Irritable Bowel Syndrome Still Routinely Disrupts Patients' Lives
- Wegmans Recalls Cheese Products Over Listeria Risk
- Red Meat Might Increase Risk Of Potentially Deadly Abdominal Aneurysm
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions